content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported): April 21, 2016</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GREENESTONE HEALTHCARE CORPORATION</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Exact name of registrant as
  specified in its charter)</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                           or other jurisdiction of</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                           Employer</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5734
                                           Yonge Street, Suite 300</B></FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>North
          York, Ontario, Canada M2M 4E7</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
      of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(416)
      222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously
  satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">[ ]</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
                                           communications pursuant to Rule 425 under the Securities Act</FONT></TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">[ ]</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
                                           material pursuant to Rule 14a-12 under the Exchange Act</FONT></TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">[ ]</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
                                           communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 15pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">[ ]</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
                                           communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
  </TR></TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 1.01</B><FONT STYLE="background-color: white"> </FONT><B>Entry into a Material
  Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">On April 13, 2016 Greenstone
  Healthcare Corporation, a Colorado corporation (the &ldquo;Company&rdquo;) entered into a Securities Purchase Agreement (the &ldquo;Purchase
  Agreement&rdquo;) with JMJ Financial, a Nevada sole proprietorship (&ldquo;JMJ,&rdquo; and together with the Company, the &ldquo;Parties&rdquo;).
  Pursuant to the Purchase Agreement, JMJ purchased from the Company (i) a Promissory Note in the aggregate principal amount of
  $500,000 (the &ldquo;Note&rdquo;), subject to an original issue discount of $50,000 (&ldquo;OID&rdquo;), and (ii) a Common Stock
  Purchase Warrant to purchase 3,703,700 shares of the Company's common stock (&ldquo;Common Stock&rdquo;) at an exercise price
  of $0.03 per share (the &ldquo;Warrant&rdquo;). </FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">Pursuant to the terms therein,
  the Purchase Agreement became effective (the &ldquo;Effective Date&rdquo;) upon (i) execution by the Parties of the Purchase Agreement,
  the Note and the Warrant, and (ii) delivery of the purchase price of $200,000, which occurred on April 15, 2016 (the &ldquo;Purchase
  Price&rdquo;). JMJ may make additional payments of up to $250,000 under the Note, in such amounts and at such times as the Parties
  may agree (the &ldquo;Additional Payments&rdquo;). Within three days of an Additional Payment, the Company shall deliver an additional
  warrant in the form of the Warrant (the &ldquo;Additional Warrant&rdquo;), with the following terms: (i) an aggregate exercise
  amount equal to 50% of the principal sum attributable to the Additional Payment, (ii) an exercise price equal to the lesser of
  $0.03 per share or the closing price per share on the date of the Additional Payment (subject to adjustments), and (iii) the number
  of shares for which the Additional Warrant is exercisable equal to the aggregate exercise amount for the Additional Warrant divided
  by the exercise price. </FONT></P>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">In addition to the OID, the
  Note bears a one-time interest charge of 10%. The maturity date is seven (7) months from the Effective Date of the Purchase Price
  or the Additional Payment, as the case may be. JMJ may extend any maturity date in its sole discretion in increments of up to
  six months at any time before or after such maturity date. The Company has no obligation to repay any unfunded portion of the
  Note. </FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">If the Company fails to repay
  the balance due under the Note, or issues a Variable Security at any time while the Note is outstanding, JMJ has the right to
  convert all or any portion of the outstanding Note into shares of Common Stock, subject to the terms and conditions set forth
  in the Note.</FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp; </FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">All amounts due under the
  Note become immediately due and payable upon the occurrence of an event of default, including but not limited to (i) the Company
  fails to pay the amounts due under the Note at maturity, (ii) the Company breaches the terms of the Note, (iii) the Company fails
  to keep available a sufficient number of authorized, unissued and unreserved shares of Common Stock pursuant to the terms of the
  Note, (iv) the Company replaces or terminates the transfer agent without JMJ&rsquo;s prior written consent, (v) the Company files
  a petition for relief under any bankruptcy, insolvency or similar law, (vi) the Common Stock has an offering price of $0.0001
  on its principal trading market at any time, (vii) the Company loses its status as DTC Eligible or its shareholders lose the ability
  to deposit shares into the DTC System, or (viii) the Company becomes delinquent in its filing requirements as a fully-reporting
  issuer registered with the Securities and Exchange Commission. </FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">The foregoing descriptions
  of the Note, the Warrant and the Purchase Agreement do not purport to be complete and are qualified in their entirety by the terms
  and conditions of such documents. Copies of the Note, the Warrant and the Purchase Agreement are attached hereto as Exhibit 4.1,
  4.2, and 10.1, respectively, and are incorporated herein by reference.</FONT></P>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 2.03</B><FONT STYLE="background-color: white"> </FONT><B>Creation of a Direct
  Financial Obligation.</B></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">The information provided in
  Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.&nbsp;</FONT></P>
  
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 3.02</B><FONT STYLE="background-color: white"> </FONT><B>Unregistered Sales
  of Equity Securities.</B></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">The applicable information
  set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. The foregoing securities
  under the Purchase Agreement were offered and sold without registration under the Securities Act of 1933, as amended (the &ldquo;</FONT>Securities
  Act<FONT STYLE="background-color: white">&rdquo;) in reliance on the exemptions provided by Section 4(a)(2) of the Securities
  Act and/or Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.</FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item&nbsp;9.01 Financial Statements And Exhibits</B></P>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="background-color: white">The following exhibits are
  furnished with this report:</FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
      <TD><A HREF="grst8k042116ex4_1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note, dated April 13, 2016</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
      <TD><A HREF="grst8k042116ex4_2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Purchase Warrant, dated April 13, 2016</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
      <TD><A HREF="grst8k042116ex10_1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated April 13, 2016</FONT></A></TD></TR>
  </TABLE>
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>
  
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the requirements of
  the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.</FONT></P>
  
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD COLSPAN="3" STYLE="padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GREENESTONE
      HEALTHCARE CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 3%; padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
      <B>April 21, 2016</B></FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
      <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;/s/
      Shawn E. Leon</I></FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
      Shawn E. Leon</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: -6.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
      Chief Executive Officer</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 4; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k042116.htm", "secsgml_size_bytes": 27792}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "161584664"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported): April 21, 2016
  GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as
  specified in its charter)
  Colorado
  000-15078
  84-1227328
  (State
                                           or other jurisdiction of
  incorporation
          or organization)
  (Commission
      File Number)
  (IRS
                                           Employer
  Identification
          No.)
  5734
                                           Yonge Street, Suite 300
  North
          York, Ontario, Canada M2M 4E7
  (Address
      of principal executive offices)
  (416)
      222-5501
  (Registrant's
      telephone number, including area code)
  Check the appropriate box below if the Form 8-K filing is intended to simultaneously
  satisfy the filing obligation of the registrant under any of the following provisions:
  [ ]
  Written
                                           communications pursuant to Rule 425 under the Securities Act
  [ ]
  Soliciting
                                           material pursuant to Rule 14a-12 under the Exchange Act
  [ ]
  Pre-commencement
                                           communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [ ]
  Pre-commencement
                                           communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Item 1.01
  Entry into a Material
  Definitive Agreement.
  On April 13, 2016 Greenstone
  Healthcare Corporation, a Colorado corporation (the "Company") entered into a Securities Purchase Agreement (the "Purchase
  Agreement") with JMJ Financial, a Nevada sole proprietorship ("JMJ," and together with the Company, the "Parties").
  Pursuant to the Purchase Agreement, JMJ purchased from the Company (i) a Promissory Note in the aggregate principal amount of
  $500,000 (the "Note"), subject to an original issue discount of $50,000 ("OID"), and (ii) a Common Stock
  Purchase Warrant to purchase 3,703,700 shares of the Company's common stock ("Common Stock") at an exercise price
  of $0.03 per share (the "Warrant").
  Pursuant to the terms therein,
  the Purchase Agreement became effective (the "Effective Date") upon (i) execution by the Parties of the Purchase Agreement,
  the Note and the Warrant, and (ii) delivery of the purchase price of $200,000, which occurred on April 15, 2016 (the "Purchase
  Price"). JMJ may make additional payments of up to $250,000 under the Note, in such amounts and at such times as the Parties
  may agree (the "Additional Payments"). Within three days of an Additional Payment, the Company shall deliver an additional
  warrant in the form of the Warrant (the "Additional Warrant"), with the following terms: (i) an aggregate exercise
  amount equal to 50% of the principal sum attributable to the Additional Payment, (ii) an exercise price equal to the lesser of
  $0.03 per share or the closing price per share on the date of the Additional Payment (subject to adjustments), and (iii) the number
  of shares for which the Additional Warrant is exercisable equal to the aggregate exercise amount for the Additional Warrant divided
  by the exercise price.
  In addition to the OID, the
  Note bears a one-time interest charge of 10%. The maturity date is seven (7) months from the Effective Date of the Purchase Price
  or the Additional Payment, as the case may be. JMJ may extend any maturity date in its sole discretion in increments of up to
  six months at any time before or after such maturity date. The Company has no obligation to repay any unfunded portion of the
  Note.
  If the Company fails to repay
  the balance due under the Note, or issues a Variable Security at any time while the Note is outstanding, JMJ has the right to
  convert all or any portion of the outstanding Note into shares of Common Stock, subject to the terms and conditions set forth
  in the Note.
  All amounts due under the
  Note become immediately due and payable upon the occurrence of an event of default, including but not limited to (i) the Company
  fails to pay the amounts due under the Note at maturity, (ii) the Company breaches the terms of the Note, (iii) the Company fails
  to keep available a sufficient number of authorized, unissued and unreserved shares of Common Stock pursuant to the terms of the
  Note, (iv) the Company replaces or terminates the transfer agent without JMJ's prior written consent, (v) the Company files
  a petition for relief under any bankruptcy, insolvency or similar law, (vi) the Common Stock has an offering price of $0.0001
  on its principal trading market at any time, (vii) the Company loses its status as DTC Eligible or its shareholders lose the ability
  to deposit shares into the DTC System, or (viii) the Company becomes delinquent in its filing requirements as a fully-reporting
  issuer registered with the Securities and Exchange Commission.
  The foregoing descriptions
  of the Note, the Warrant and the Purchase Agreement do not purport to be complete and are qualified in their entirety by the terms
  and conditions of such documents. Copies of the Note, the Warrant and the Purchase Agreement are attached hereto as Exhibit 4.1,
  4.2, and 10.1, respectively, and are incorporated herein by reference.
  Item 2.03
  Creation of a Direct
  Financial Obligation.
  The information provided in
  Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
  Item 3.02
  Unregistered Sales
  of Equity Securities.
  The applicable information
  set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. The foregoing securities
  under the Purchase Agreement were offered and sold without registration under the Securities Act of 1933, as amended (the "
  Securities
  Act
  ") in reliance on the exemptions provided by Section 4(a)(2) of the Securities
  Act and/or Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable state laws.
  Item 9.01 Financial Statements And Exhibits
  The following exhibits are
  furnished with this report:
  Exhibit
      No.
  Exhibit
      Description
  4.1
  Promissory Note, dated April 13, 2016
  4.2
  Common Stock Purchase Warrant, dated April 13, 2016
  10.1
  Securities Purchase Agreement, dated April 13, 2016
  SIGNATURES
  Pursuant to the requirements of
  the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  GREENESTONE
      HEALTHCARE CORPORATION
  Date:
  April 21, 2016
  By:
  /s/
      Shawn E. Leon
  Name:
      Shawn E. Leon
  Title:
      Chief Executive Officer